首页> 美国卫生研究院文献>Chemical Science >A novel restriction endonuclease GlaI for rapid and highly sensitive detection of DNA methylation coupled with isothermal exponential amplification reaction
【2h】

A novel restriction endonuclease GlaI for rapid and highly sensitive detection of DNA methylation coupled with isothermal exponential amplification reaction

机译:新型限制性核酸内切酶GlaI用于快速高度灵敏地检测DNA甲基化并结合等温指数扩增反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sensitive and accurate detection of site-specific DNA methylation is of critical significance for early diagnosis of human diseases, especially cancers. Herein, for the first time we employ a novel methylation-dependent restriction endonuclease GlaI to detect site-specific DNA methylation in a highly specific and sensitive way by coupling with isothermal exponential amplification reaction (EXPAR). GlaI can only cut the methylated target site with excellent selectivity but leave the unmethylated DNA intact. Then the newly exposed end fragments of methylated DNA can trigger EXPAR for highly efficient signal amplification while the intact unmethylated DNA will not initiate EXPAR at all. As such, only the methylated DNA is quantitatively and faithfully reflected by the real-time fluorescence signal of the GlaI–EXPAR system, and the potential false positive interference from unmethylated DNA can be effectively eliminated. Therefore, by integrating the unique features of GlaI for highly specific methylation discrimination and EXPAR for rapid and powerful signal amplification, the elegant GlaI–EXPAR assay allows the direct quantification of methylated DNA with ultrahigh sensitivity and accuracy. The detection limit of methylated DNA target has been pushed down to the aM level and the whole detection process of GlaI–EXPAR can be accomplished within a short time of 2 h. More importantly, ultrahigh specificity is achieved and as low as 0.01% methylated DNA can be clearly identified in the presence of a large excess of unmethylated DNA. This GlaI–EXPAR is also demonstrated to be capable of determining site-specific DNA methylations in real genomic DNA samples. Sharing the distinct advantages of ultrahigh sensitivity, outstanding specificity and facile operation, this new GlaI–EXPAR strategy may provide a robust and reliable platform for the detection of site-specific DNA methylations with low abundances.
机译:敏感和准确地检测特定于位点的DNA甲基化对于人类疾病(尤其是癌症)的早期诊断至关重要。在本文中,我们首次采用新颖的甲基化依赖性限制性内切核酸酶GlaI,通过与等温指数扩增反应(EXPAR)结合,以高度特异性和灵敏的方式检测位点特异性DNA甲基化。 GlaI只能以极好的选择性切割甲基化的靶位点,而完整地保留未甲基化的DNA。然后,新暴露的甲基化DNA末端片段可以触发EXPAR进行高效信号放大,而完整的未甲基化DNA根本不会启动EXPAR。因此,GlaI-EXPAR系统的实时荧光信号只能定量地忠实地反映甲基化的DNA,并且可以有效地消除未甲基化的DNA产生的假阳性干扰。因此,通过整合GlaI用于高特异性甲基化识别的独特功能和EXPAR用于快速而强大的信号放大的独特功能,优雅的GlaI–EXPAR检测方法可以以超高的灵敏度和准确性直接定量甲基化的DNA。甲基化DNA靶标的检测限已降低到aM水平,并且GlaI–EXPAR的整个检测过程可以在2小时内完成。更重要的是,在存在大量过量的未甲基化DNA的情况下,可以实现超高特异性,并且可以清楚地识别出低至0.01%的甲基化DNA。这种GlaI–EXPAR也被证明能够确定真实基因组DNA样品中的位点特异性DNA甲基化。这种新的GlaI–EXPAR策略具有超高灵敏度,出色的特异性和操作简便的独特优势,可为检测低丰度的位点特异性DNA甲基化提供强大而可靠的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号